DrugPatentWatch Database Preview
Clovis Oncology Inc Company Profile
What is the competitive landscape for CLOVIS ONCOLOGY INC, and what generic alternatives to CLOVIS ONCOLOGY INC drugs are available?
CLOVIS ONCOLOGY INC has one approved drug.
There are ten US patents protecting CLOVIS ONCOLOGY INC drugs.
There are two hundred and sixteen patent family members on CLOVIS ONCOLOGY INC drugs in fifty-two countries and fourteen supplementary protection certificates in thirteen countries.
Summary for Clovis Oncology Inc
| International Patents: | 216 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Clovis Oncology Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-003 | May 1, 2017 | RX | Yes | No | 7,531,530 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-003 | May 1, 2017 | RX | Yes | No | 8,754,072 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-001 | Dec 19, 2016 | RX | Yes | No | 7,351,701 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-001 | Dec 19, 2016 | RX | Yes | No | 7,531,530 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-002 | Dec 19, 2016 | RX | Yes | Yes | 9,045,487 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Clovis Oncology Inc | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-001 | Dec 19, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Clovis Oncology Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3150610 | ➤ Try a Free Trial |
| South Africa | 200105399 | ➤ Try a Free Trial |
| Taiwan | I545123 | ➤ Try a Free Trial |
| United Kingdom | 0317466 | ➤ Try a Free Trial |
| South Korea | 101136702 | ➤ Try a Free Trial |
| Brazil | PI0417056 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Clovis Oncology Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1633724 | S1500012 | Hungary | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB |
| 1633724 | 213 50005-2015 | Slovakia | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB; REGISTRATION NO/DATE: EU/1/14/959 20141218 |
| 1633724 | 1590019-4 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB, AND SALTS AND SOLVATES THEREOF; REG. NO/DATE: EU/1/14/959 20141218 |
| 1633724 | PA2015016,C1633724 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIBAS IR JO DRUSKOS IR SOLVATAI; REGISTRATION NO/DATE: EU/1/14/959 20141216 |
| 1633724 | CR 2015 00012 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB, OG SALTE OG SOLVATER DERAF; REG. NO/DATE: EU/1/14/959/001 20141216 |
| 1633724 | 2015/016 | Ireland | ➤ Try a Free Trial | PRODUCT NAME: OLAPARIB, AND SALTS AND SOLVATES THEREOF; REGISTRATION NO/DATE: EU/1/14/959/001 20141216 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
